Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
MAPK signaling pathway	19/314	3.779506776680692E-4	0.5707055232787844	0	0	2.4203821656050954	19.074419135176974	MINK1;HSPB1;TRAF2;CACNA2D4;ARRB2;CACNA1F;MAPK8IP3;MAPK12;GADD45G;CACNA1G;FGF17;PPP5C;EEF2K;TAOK2;EIF4EBP1;MAP3K6;FGF12;SIPA1;MAP3K5
Endocytotic role of NDK, phosphins and dynamin	4/17	7.089723556156057E-4	0.5352741284897823	0	0	9.411764705882351	68.25123786222498	BIN1;NME2;DNM1;EPN1
Downregulation of MTA-3 in ER-negative breast tumors	4/18	8.936428005945616E-4	0.449800209632596	0	0	8.888888888888888	62.40181701813813	MTA1;HSPB1;ALDOA;TUBA4A
Neuronal system	16/283	0.002143948617453744	0.8093406030887884	0	0	2.261484098939929	13.897059509372431	CAMK2B;KCNJ4;KCNH3;AKAP5;COMT;CPLX1;PANX2;KCNV2;GNGT2;GNB2;DNAJC5;GNB3;SLC17A7;STX3;HCN2;KCNK3
Mammalian target of rapamycin complex 1 (mTORC1)-mediated signaling	3/11	0.002206288138266319	0.6662990177564283	0	0	10.909090909090908	66.72484091962643	EEF2K;EIF4EBP1;MLST8
p38 gamma/delta MAPK pathway	3/11	0.002206288138266319	0.5552491814636903	0	0	10.909090909090908	66.72484091962643	EEF2K;PKN1;MAPK12
Visual signal transduction: cones	4/23	0.0023425796244436227	0.5053278904156958	0	0	6.956521739130435	42.13219167446808	GUCY2D;GNGT2;GNB3;PDE6C
p53 activity regulation	9/118	0.0028606544429483588	0.5399485261065027	0	0	3.0508474576271185	17.86791311426861	PIDD1;CDKN2A;E2F1;PIN1;BAX;E4F1;CSNK1G2;GADD45G;TP73
EGF/EGFR signaling pathway	10/141	0.0029128011306778045	0.4887033008137205	0	0	2.8368794326241136	16.563517937383136	NDUFA13;IQSEC1;TNK2;E2F1;MYBL2;ARHGEF1;SH3GL2;DNM1;EPN1;BCAR1
Inositol phosphate metabolism	6/57	0.002922860473264887	0.441351931462998	0	0	4.2105263157894735	24.569231697174438	ISYNA1;IMPA2;ITPKA;INPP5J;PIP5K1C;PLCD3
Phosphatidylinositol signaling system	7/78	0.003350695028406084	0.4599590448084715	0	0	3.5897435897435894	20.456467889481193	IMPA2;ITPKA;INPP5J;ITPR3;PIP5K1C;PLCD3;DGKZ
Potassium channels	8/99	0.0033865002825074135	0.42613461888218285	0	0	3.2323232323232323	18.38531961499045	KCNJ4;KCNH3;KCNV2;GNGT2;GNB2;GNB3;HCN2;KCNK3
p73 transcription factor network	7/79	0.003599159183618213	0.4180561820971924	0	0	3.5443037974683542	19.94399247915885	JAG2;BIN1;HSF1;BAX;PIN1;AEN;TP73
Insulin secretion regulation by glucagon-like peptide-1	5/43	0.004211385981886807	0.4542280594749342	0	0	4.651162790697674	25.44169057496083	GNGT2;GNB2;GNB3;ITPR3;AKAP5
Endocytosis	12/201	0.004811309721838535	0.48433851199841255	0	0	2.388059701492537	12.744563439967834	PSD;IQSEC1;CLTB;PIP5K1C;ARRB2;ARAP1;GIT1;SH3GL2;DNM1;EPN1;RAB11B;SH3GL1
PKB-mediated events	4/28	0.00490889575807688	0.46327703716850555	0	0	5.7142857142857135	30.381178622804246	STK11;EEF2K;EIF4EBP1;MLST8
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	6/64	0.005218196737777777	0.463498651414379	0	0	3.75	19.708512709886456	ITPR3;ARRB2;PLCH2;PLCD3;MAPK12;MAP3K5
Platelet activation, signaling and aggregation	12/205	0.005614766164860565	0.47101649494108067	0	0	2.341463414634146	12.134295421780498	GNGT2;GNB2;VEGFB;GNB3;ITPR3;ACTN4;ARRB2;ALDOA;GAS6;DGKZ;TUBA4A;BCAR1
HES/HEY pathway	5/48	0.0067673334453859715	0.5378249211859377	0	0	4.166666666666667	20.815200615542235	NCOR2;CTBP1;GAA;E2F1;GATA4
Inwardly rectifying potassium channels	4/31	0.007112686652484723	0.5370078422625967	0	0	5.161290322580645	25.527097997387994	KCNJ4;GNGT2;GNB2;GNB3
Axon guidance	16/325	0.008053713159505085	0.5791003271834609	0	0	1.9692307692307691	9.494886462719963	SPTBN4;ROBO3;SEMA5B;UNC5A;PLXND1;SEMA3F;CACNA1F;SPTB;DNM1;CACNA1G;COL5A1;PLXNB2;PIP5K1C;SCN1B;SH3GL2;PAK4
Nucleotide metabolism	6/70	0.008055338225300687	0.552889123645638	0	0	3.4285714285714284	16.530583795713788	GPX1;GUK1;IMPDH1;NME2;AMPD2;TK1
ABCA transporters in lipid homeostasis	3/17	0.00813412351983557	0.5340228919544223	0	0	7.0588235294117645	33.96485143053246	ABCA2;ABCA3;ABCA7
Post-chaperonin tubulin folding pathway	3/17	0.00813412351983557	0.511771938122988	0	0	7.0588235294117645	33.96485143053246	TBCD;TUBB4B;TUBA4A
Purine metabolism	10/164	0.008359541630999804	0.5049163145123882	0	0	2.4390243902439024	11.669150444430382	GPX1;GUCY2D;GUK1;IMPDH1;POLD1;NME2;POLR2E;NME3;PDE6C;AMPD2
eIF4E release	2/6	0.0087524127649488	0.508313202887411	0	0	13.333333333333332	63.17901162743442	EIF4EBP1;MLST8
Amyotrophic lateral sclerosis (ALS)	5/53	0.01024902420142917	0.5731861683021499	0	0	3.7735849056603774	17.285180293547484	GPX1;TOMM40;BAX;MAPK12;MAP3K5
Thrombin signaling through protease-activated receptors	5/53	0.01024902420142917	0.5527152337199303	0	0	3.7735849056603774	17.285180293547484	GNGT2;GNB2;GNB3;ARHGEF1;ARRB2
E2F transcription factor network	6/74	0.010475384097409076	0.5454424133478519	0	0	3.2432432432432434	14.78506101352144	CDKN2C;CDKN2A;E2F1;MYBL2;TK1;TP73
TP53 network	3/19	0.011170818168534696	0.5622645144829129	0	0	6.31578947368421	28.386002662889787	CDKN2A;BAX;TP73
Granule cell survival pathway	7/99	0.012108679485786067	0.5898098717269987	0	0	2.828282828282828	12.483567432142767	KCNV2;BAX;NPTX1;PLCH2;PLCD3;KCNK3;MAP3K5
ID regulation of gene expression	3/20	0.012902143644594305	0.6088199032292938	0	0	5.999999999999999	26.10217084452193	CDKN2A;GATA4;SEMA3F
Integration of energy metabolism	8/125	0.013327245294946983	0.6098224362233317	0	0	2.56	11.053938740966716	STK11;GNGT2;GNB2;FFAR4;GNB3;GATA4;ITPR3;AKAP5
Cyclin D-associated events in G1	4/38	0.014554726485956956	0.6464010880527942	0	0	4.2105263157894735	17.80985049987152	CDKN2C;CDKN2A;E2F1;PPP2R3B
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase	3/21	0.014777987746011578	0.6375646141850709	0	0	5.7142857142857135	24.083522970404665	CAMK2B;ARHGEF1;PKN1
Presynaptic function of kainate receptors	3/21	0.014777987746011578	0.6198544860132634	0	0	5.7142857142857135	24.083522970404665	GNGT2;GNB2;GNB3
Nucleotide excision repair	5/58	0.014793960819046157	0.6037535361286406	0	0	3.4482758620689657	14.52943529053588	XAB2;LIG1;POLD1;POLR2E;RAD23A
S6K1 signaling	2/8	0.01580491452517871	0.6280373929742066	0	0	10.0	41.47434341416576	EEF2K;MLST8
Caspase cascade in apoptosis	5/59	0.015841491499778683	0.6133500555042516	0	0	3.389830508474576	14.05126351420034	PIDD1;NUMA1;BAX;TRAF2;LMNB2
Metabolism	54/1615	0.017425370948002727	0.657807753287103	0	0	1.3374613003095974	5.416488268782459	NDUFA13;NDUFA11;CHPF;GPAA1;ECI1;MED16;COMT;ENO3;GNGT2;IMPA2;GUK1;BSG;FFAR4;TK1;ACADS;GAMT;GPX1;GAA;NME2;NME3;NOSIP;AMPD2;CEL;DGKZ;NCOR2;DPM3;NDUFS7;ITPKA;PHPT1;ALDOA;CSNK1G2;ISYNA1;NDUFB7;SHMT2;GSTP1;PDXP;GATA4;ITPR3;AKAP5;POLD1;UAP1L1;ST3GAL4;POLR2E;INPP5J;PIP5K1C;NDUFV1;B3GAT3;PFKL;IMPDH1;GNB2;PEMT;GNB3;PLCD3;GALK1
Cyclins and cell cycle regulation	3/23	0.01896828932905573	0.6985882167530281	0	0	5.217391304347825	20.686887009392155	CDKN2C;CDKN2A;E2F1
Incretin biosynthesis, secretion, and inactivation	3/23	0.01896828932905573	0.6819551639731941	0	0	5.217391304347825	20.686887009392155	FFAR4;GNB3;GATA4
Developmental biology	18/420	0.019271776307225475	0.6767530749746621	0	0	1.7142857142857142	6.769909064358	SPTBN4;ROBO3;UNC5A;PLXND1;MED16;CACNA1F;SPTB;DNM1;MAPK12;CACNA1G;NCOR2;NEUROD1;DRAP1;COL5A1;PIP5K1C;SCN1B;SH3GL2;PAK4
Type I hemidesmosome assembly	2/9	0.019987498286726836	0.6859346002944892	0	0	8.888888888888888	34.779095880349324	LAMA3;PLEC
Bladder cancer	4/42	0.020420811588340845	0.6852316777421039	0	0	3.8095238095238093	14.82362179908072	CDKN2A;DAPK3;E2F1;VEGFB
Transmission across chemical synapses	10/190	0.021516407975661487	0.7062994792010618	0	0	2.1052631578947367	8.081977838420274	CAMK2B;KCNJ4;GNGT2;GNB2;DNAJC5;GNB3;SLC17A7;AKAP5;COMT;CPLX1
Mitotic G2-G2/M phases	6/87	0.021837635299768118	0.7015921128223375	0	0	2.758620689655172	10.549297676655467	NUMA1;CEP131;E2F1;PKMYT1;TUBB4B;TUBA4A
Beta-1 integrin cell surface interactions	5/66	0.02457069252754745	0.7729530357624301	0	0	3.0303030303030303	11.230911839233022	LAMA5;COL5A1;COL7A1;LAMA3;NPNT
DCC role in regulating apoptosis	2/10	0.02457569018526242	0.7573324934642093	0	0	8.0	29.64798022792225	UNC5A;DAPK3
Gap junction degradation	2/10	0.02457569018526242	0.7421858435949251	0	0	8.0	29.64798022792225	CLTB;DNM1
Fas signaling pathway	7/115	0.02547970400822695	0.7543990794592684	0	0	2.4347826086956523	8.935343114727202	HSPB1;BAX;TRAF2;CSNK1G2;MAPK12;MAP3K5;PLEC
RhoA signaling pathway	4/45	0.02564991223851159	0.7448339900029327	0	0	3.5555555555555554	13.024764902655056	PIP5K1C;PKN1;SH3GL2;MAPK12
Galactose metabolism	3/26	0.026359322007969647	0.7509920043780032	0	0	4.615384615384615	16.781230569993895	PFKL;GAA;GALK1
Interaction between L1-type proteins and ankyrins	3/26	0.026359322007969647	0.7370847450376699	0	0	4.615384615384615	16.781230569993895	SPTBN4;SPTB;SCN1B
AMPK signaling	5/68	0.02753519263940741	0.7559661979182761	0	0	2.941176470588235	10.565559882726514	STK11;EEF2K;EIF4EBP1;EEF2;SLC2A4RG
Syndecan 1 pathway	4/46	0.02755542815386633	0.7430124377203242	0	0	3.4782608695652173	12.492367769086824	LAMA5;COL5A1;COL7A1;BSG
ADP signalling through P2Y purinoceptor 12	3/27	0.029117852235481113	0.7713676644837979	0	0	4.444444444444444	15.717350284548534	GNGT2;GNB2;GNB3
Glycolysis	3/27	0.029117852235481113	0.758068221992698	0	0	4.444444444444444	15.717350284548534	PFKL;ALDOA;ENO3
Agrin in postsynaptic differentiation	4/47	0.029543217073038634	0.7561060640726837	0	0	3.4042553191489358	11.98945056052437	LAMA5;LAMA3;DVL1;PAK4
Down syndrome cell adhesion molecule (DSCAM) interactions	2/11	0.02954667996708659	0.7435914458383459	0	0	7.2727272727272725	25.612973778194785	DSCAML1;MAPK12
E2F1 destruction pathway	2/11	0.02954667996708659	0.731401422136078	0	0	7.2727272727272725	25.612973778194785	CDC34;E2F1
Integrin beta-4 pathway	2/11	0.02954667996708659	0.7196046250048509	0	0	7.2727272727272725	25.612973778194785	LAMA5;LAMA3
NCAM signaling for neurite out-growth	5/70	0.03071766872573008	0.7362488853309909	0	0	2.8571428571428568	9.951192175476	SPTBN4;COL5A1;CACNA1F;SPTB;CACNA1G
G-protein activation	3/28	0.03202293203002463	0.7555410525833937	0	0	4.285714285714286	14.748441458133852	GNGT2;GNB2;GNB3
G-protein beta-gamma signalling	3/28	0.03202293203002463	0.7439173440821106	0	0	4.285714285714286	14.748441458133852	GNGT2;GNB2;GNB3
Focal adhesion	11/233	0.0330268350129832	0.7556139525697672	0	0	1.888412017167382	6.440306184263214	LAMA5;COL5A1;TNK2;LAMA3;VEGFB;ACTN4;PIP5K1C;THBS4;MAPK12;BCAR1;PAK4
Inhibition of replication initiation of damaged DNA by RB1/E2F1	2/12	0.03487854042134841	0.7860685975557626	0	0	6.666666666666666	22.372556843567576	E2F1;PPP2R3B
Inhibition of insulin secretion by adrenaline/noradrenaline	3/29	0.035073626746766035	0.7788408292296575	0	0	4.137931034482758	13.863334368288841	GNGT2;GNB2;GNB3
Phototransduction	3/29	0.035073626746766035	0.7675532809799523	0	0	4.137931034482758	13.863334368288841	RCVRN;GUCY2D;ARRB2
Post-translational modification: biosynthesis of GPI-anchored proteins	3/29	0.035073626746766035	0.7565882341088102	0	0	4.137931034482758	13.863334368288841	DPM3;GPAA1;PIGZ
Translation factors	4/50	0.036004517553649654	0.7657298803663518	0	0	3.1999999999999997	10.637154754552185	EEF2K;CLUH;EIF4EBP1;EEF2
Wnt/calcium/cyclic GMP pathway	5/74	0.037751290429200716	0.7917284520568484	0	0	2.7027027027027026	8.856042217071249	CAMK2B;PDE6C;ITPR3;PLCH2;PLCD3
Activation of kainate receptors upon glutamate binding	3/30	0.038268755933891604	0.7915865953448811	0	0	4.0	13.052485950718438	GNGT2;GNB2;GNB3
HIV life cycle early phase	2/13	0.040550197611673826	0.8274432215355064	0	0	6.153846153846154	19.724397693220933	LIG1;HMGA1
Myometrial relaxation and contraction pathways	8/155	0.04127099252559589	0.8309226495153307	0	0	2.064516129032258	6.580842087103301	CAMK2B;GNB2;IGFBP2;GNB3;ITPR3;ARRB2;DGKZ;RAMP1
Activated NOTCH1 signaling in the nucleus	3/31	0.04160691113161275	0.826663629062306	0	0	3.8709677419354835	12.307699325969082	JAG2;MIB2;ARRB2
Alpha-6 beta-4 integrin signaling pathway	3/31	0.04160691113161275	0.8159277377757825	0	0	3.8709677419354835	12.307699325969082	LAMA5;LAMA3;EIF4EBP1
Signal amplification	3/31	0.04160691113161275	0.805467125753016	0	0	3.8709677419354835	12.307699325969082	GNGT2;GNB2;GNB3
GABA A and B receptor activation	4/53	0.04321791047116662	0.8260638583729315	0	0	3.0188679245283017	9.48377441633977	KCNJ4;GNGT2;GNB2;GNB3
G alpha (12/13) signaling events	5/77	0.0436226954523553	0.8233783766632063	0	0	2.597402597402597	8.1355265614596	GNGT2;GNB2;ARHGEF16;GNB3;ARHGEF1
Retrograde neurotrophin signaling	2/14	0.04654140207685347	0.8676236683462808	0	0	5.7142857142857135	17.52807425877975	DNM1;SH3GL2
Visual signal transduction	2/14	0.04654140207685347	0.8570428919030335	0	0	5.7142857142857135	17.52807425877975	RCVRN;GNGT2
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	5/79	0.047824533823498286	0.8700607960660531	0	0	2.5316455696202533	7.696750661396753	MLST8;EIF4EBP1;SH3GL2;BCAR1;PAK4
E2F-mediated regulation of DNA replication	3/33	0.048705626415457094	0.875541617706431	0	0	3.6363636363636362	10.988948085170936	CDT1;E2F1;PPP2R3B
Glucagon-type ligand receptors	3/33	0.048705626415457094	0.8652411280863554	0	0	3.6363636363636362	10.988948085170936	GNGT2;GNB2;GNB3
Adipogenesis	7/133	0.049764409625326224	0.8737704480725883	0	0	2.1052631578947367	6.316747824432069	NCOR2;CNTFR;DVL1;HMGA1;E2F1;GATA4;MIF
Apoptosis modulation and signaling	5/80	0.05001216613714395	0.8680272513458318	0	0	2.5	7.488722451023223	PIDD1;ENDOG;CDKN2A;BAX;MAP3K5
Respiratory electron transport, ATP biosynthesis by chemiosmotic coupling, and heat production by uncoupling proteins	5/81	0.05225771474036599	0.8966948779312799	0	0	2.4691358024691357	7.287821601242378	NDUFA13;NDUFB7;NDUFA11;NDUFS7;NDUFV1
Fructose and mannose metabolism	3/34	0.0524623778440582	0.890092028590201	0	0	3.5294117647058822	10.403502278005256	PFKL;ALDOA;PHPT1
Association of licensing factors with the pre-replicative complex	2/15	0.05283270093282616	0.88641531565075	0	0	5.333333333333333	15.683333035361262	CDT1;E2F1
Lagging strand processive biosynthesis	2/15	0.05283270093282616	0.8766744880062363	0	0	5.333333333333333	15.683333035361262	LIG1;POLD1
Mitotic G1-G1/S phases	7/135	0.05313609019450785	0.8721249586272484	0	0	2.074074074074074	6.087197753615342	CDT1;CDKN2C;CDKN2A;E2F1;MYBL2;PPP2R3B;PKMYT1
Arf6 signal transduction regulation	3/35	0.056354567885378765	0.9150042742679778	0	0	3.4285714285714284	9.860886785287258	IQSEC1;ARRB2;GIT1
HIV-1 Nef as negative effector of Fas and TNF	4/58	0.05691072142191488	0.9142041419903347	0	0	2.758620689655172	7.9069559445711395	NUMA1;TRAF2;LMNB2;MAP3K5
Response to elevated platelet cytosolic calcium	5/83	0.05692265803393813	0.9047706698025956	0	0	2.4096385542168672	6.906173034062129	VEGFB;ACTN4;ALDOA;GAS6;TUBA4A
Protein processing in the endoplasmic reticulum	8/166	0.05740655631414082	0.9029572920245067	0	0	1.927710843373494	5.508620261549271	PRKCSH;DNAJC5;LMAN2;BAX;RAD23A;TRAF2;STUB1;MAP3K5
Actin cytoskeleton regulation	10/226	0.05846014101338836	0.9100496178372828	0	0	1.7699115044247786	5.025504614455491	FGF17;CHRM4;RASSF7;ARHGEF1;ACTN4;PIP5K1C;FGF12;GIT1;BCAR1;PAK4
Gap-filling DNA repair biosynthesis and ligation in global genomic nucleotide excision repair	2/16	0.05940541077305161	0.9153282680337543	0	0	5.0	14.116849831533036	LIG1;POLD1
Glutamate neurotransmitter release cycle	2/16	0.05940541077305161	0.9060825279526052	0	0	5.0	14.116849831533036	SLC17A7;CPLX1
Rap1 signaling	2/16	0.05940541077305161	0.8970217026730792	0	0	5.0	14.116849831533036	RAP1GAP;SIPA1
Neurotransmitter release cycle	3/36	0.06037988610364689	0.9027091882822457	0	0	3.333333333333333	9.356997470103483	DNAJC5;SLC17A7;CPLX1
mTOR signaling pathway	6/113	0.06431776483525216	0.9521551460904977	0	0	2.1238938053097343	5.82779342742149	STK11;EEF2K;EIF4EBP1;MLST8;VEGFB;EEF2
Pathways in cancer	13/325	0.06589649084139472	0.9660553511699614	0	0	1.5999999999999999	4.351472141828339	LAMA5;CTBP1;CDKN2A;GSTP1;DAPK3;LAMA3;VEGFB;TRAF2;FGF17;DVL1;E2F1;BAX;FGF12
Eukaryotic protein translation	2/17	0.0662415915707929	0.9617769545374739	0	0	4.705882352941176	12.773867020503221	EEF2K;EEF2
G1/S-specific transcription	2/17	0.0662415915707929	0.9526171740180693	0	0	4.705882352941176	12.773867020503221	CDT1;E2F1
Signaling events mediated by focal adhesion kinase	4/62	0.06934618550712146	0.9878560388278623	0	0	2.5806451612903225	6.886823579964537	ACTN4;MAPK8IP3;BCAR1;SH3GL1
G13 signaling pathway	3/39	0.07322950908508677	1.0	0	0	3.076923076923077	8.04355941437563	TNK2;ARHGEF1;PKN1
Effect of METS on macrophage differentiation	2/18	0.07332402120449992	1.0	0	0	4.444444444444444	11.612742279715478	NCOR2;E2F1
Nucleotide di- and triphosphate biosynthesis and interconversion	2/18	0.07332402120449992	1.0	0	0	4.444444444444444	11.612742279715478	GUK1;NME2
Tricarboxylic acid (TCA) cycle and respiratory electron transport	6/117	0.0734450920200029	1.0	0	0	2.051282051282051	5.356342972900848	NDUFA13;NDUFB7;NDUFA11;NDUFS7;BSG;NDUFV1
Signaling by NOTCH	6/119	0.07827229040395454	1.0	0	0	2.0168067226890756	5.137939419297049	JAG2;NCOR2;ST3GAL4;E2F1;MIB2;ARRB2
GABA biosynthesis, release, reuptake and degradation	2/19	0.08063617099611983	1.0	0	0	4.2105263157894735	10.601296667256518	DNAJC5;CPLX1
Resolution of abasic sites (AP sites)	2/19	0.08063617099611983	1.0	0	0	4.2105263157894735	10.601296667256518	LIG1;POLD1
ERBB1 internalization pathway	3/41	0.08241355278955437	1.0	0	0	2.9268292682926824	7.305381599970589	SH3GL2;DNM1;EPN1
Retinoblastoma protein regulation	4/66	0.08305732510112497	1.0	0	0	2.4242424242424243	6.03205877749113	CTBP1;CDKN2A;E2F1;PPP2R3B
cAMP cell motility pathway inferred from amoeba model	4/67	0.08667836668553372	1.0	0	0	2.388059701492537	5.840121660964135	PDE6C;ITPR3;PLCH2;PLCD3
L1CAM interactions	5/94	0.08668636111653329	1.0	0	0	2.127659574468085	5.203103657017745	SPTBN4;SPTB;SCN1B;SH3GL2;DNM1
Amine ligand-binding G-protein coupled receptors	3/42	0.08718222910547488	1.0	0	0	2.8571428571428568	6.970727895708977	HTR6;CHRM4;DRD4
4-1BB-dependent immune response	2/20	0.08816218183787267	1.0	0	0	4.0	9.714308741076266	TRAF2;MAP3K5
RNA polymerase III abortive and retractive initiation	2/20	0.08816218183787267	1.0	0	0	4.0	9.714308741076266	NFIC;POLR2E
G-protein signaling pathways	5/95	0.08973008930567587	1.0	0	0	2.1052631578947367	5.075682362950664	GNGT2;GNB2;GNB3;ARHGEF1;AKAP5
Integrin signaling pathway	7/155	0.09461742127485875	1.0	0	0	1.8064516129032255	4.25945693896194	RHOT2;CDKN2A;TNK2;TSPAN4;MAPK12;BCAR1;MAP3K5
Mitochondrial role in apoptotic signaling	2/21	0.09588684119947874	1.0	0	0	3.8095238095238093	8.931758172484527	ENDOG;BAX
Nicotine activity on dopaminergic neurons	2/21	0.09588684119947874	1.0	0	0	3.8095238095238093	8.931758172484527	DRD4;KCNK3
Prion pathway	2/21	0.09588684119947874	1.0	0	0	3.8095238095238093	8.931758172484527	LAMA5;LAMA3
TSH regulation of gene expression	5/97	0.09598139817691856	1.0	0	0	2.0618556701030926	4.832166753155399	TNK2;E2F1;VEGFB;CYBA;NRGN
NCAM1 interactions	3/44	0.09705771960273352	1.0	0	0	2.727272727272727	6.361225718177528	COL5A1;CACNA1F;CACNA1G
MicroRNA regulation of DNA damage response	4/70	0.09798976602376523	1.0	0	0	2.2857142857142856	5.309467963642306	PIDD1;E2F1;BAX;GADD45G
Bacterial invasion of epithelial cells	4/71	0.10190606046315834	1.0	0	0	2.2535211267605635	5.14637490908864	MAD2L2;CLTB;DNM1;BCAR1
Melanoma	4/71	0.10190606046315834	1.0	0	0	2.2535211267605635	5.14637490908864	FGF17;CDKN2A;E2F1;FGF12
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	4/71	0.10190606046315834	1.0	0	0	2.2535211267605635	5.14637490908864	ENDOG;BAX;ITPR3;MAP3K5
G alpha (z) signaling events	3/45	0.10215828081331627	1.0	0	0	2.6666666666666665	6.0832850553957645	GNGT2;GNB2;GNB3
Senescence and autophagy	5/99	0.10244796021859995	1.0	0	0	2.02020202020202	4.602828918210063	CDKN2A;FKBP8;HMGA1;MLST8;E2F1
Glycosaminoglycan biosynthesis: chondroitin sulfate	2/22	0.10379556080326813	1.0	0	0	3.6363636363636362	8.237571185428129	CHPF;B3GAT3
Cell-cell communication	6/129	0.10499814284251867	1.0	0	0	1.8604651162790697	4.19313975106073	LAMA3;CDH24;ACTN4;DSCAML1;MAPK12;PLEC
Pyrimidine metabolism	5/100	0.10576065482120137	1.0	0	0	2.0	4.4931534226415195	POLD1;NME2;POLR2E;NME3;TK1
Myocyte adrenergic pathway	4/72	0.10589336254947611	1.0	0	0	2.222222222222222	4.989606010945918	CAMK2N2;ARRB2;CACNA1F;HCN2
RhoA activity regulation	3/46	0.10736313441562158	1.0	0	0	2.6086956521739126	5.821404549935052	MYO9B;ARHGEF1;ARAP1
Signaling by NOTCH1	4/73	0.10995046855934236	1.0	0	0	2.191780821917808	4.838849973529832	NCOR2;JAG2;MIB2;ARRB2
Mismatch repair	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	LIG1;POLD1
Mitochondrial fatty acid beta-oxidation	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	ECI1;ACADS
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	BAX;MAPK12
RNA polymerase III transcription termination	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	NFIC;POLR2E
Signaling events mediated by PRL	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	PTP4A3;BCAR1
ABC transporters	3/47	0.11266904115423244	1.0	0	0	2.553191489361702	5.57438450312141	ABCA2;ABCA3;ABCA7
Presenilin action in Notch and Wnt signaling	3/48	0.11807273003133849	1.0	0	0	2.5	5.341136220470389	CTBP1;DVL1;KREMEN2
AMPK inhibition of chREBP transcriptional activation activity	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	STK11
APOBEC3G-mediated resistance to HIV-1 infection	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	HMGA1
Abacavir metabolism	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	GUK1
Activation of NOXA and translocation to mitochondria	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	E2F1
Axonal growth stimulation	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	ARHGEF1
Dopamine receptors	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	DRD4
Electric transmission across gap junctions	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	PANX2
G2 phase pathway	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	E2F1
Gene expression regulation in endocrine-committed (NEUROG3+) progenitor cells	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	NEUROD1
Muscarinic acetylcholine receptors	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CHRM4
Plexin D1 signaling	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	PLXND1;IQSEC1
Tumor suppressor Arf inhibits ribosomal biogenesis	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	CDKN2A;E2F1
Amoebiasis	5/105	0.12309486929886125	1.0	0	0	1.9047619047619047	3.99009509674713	LAMA5;COL5A1;LAMA3;HSPB1;ACTN4
DNA repair	5/105	0.12309486929886125	1.0	0	0	1.9047619047619047	3.99009509674713	MAD2L2;XAB2;LIG1;POLD1;POLR2E
Fibroblast growth factor receptor pathway	5/105	0.12309486929886125	1.0	0	0	1.9047619047619047	3.99009509674713	FGF17;EEF2K;CDKN2A;FGF12;MAPK12
Arf6 integrin-mediated signaling pathway	3/49	0.12357090514220292	1.0	0	0	2.4489795918367343	5.120669772142008	BIN1;PIP5K1C;MAPK8IP3
Alpha-9 beta-1 integrin pathway	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	ADAM15;BCAR1
C-Myc pathway	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	CDKN2A;PIN1
Fatty acid biosynthesis	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	ECH1;ECHDC2
G0 and early G1 pathway	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	E2F1;MYBL2
PIP2 hydrolysis	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	ITPR3;DGKZ
Aquaporin-mediated transport	3/50	0.12916025190606503	1.0	0	0	2.4	4.912083318606716	GNGT2;GNB2;GNB3
Hemostasis pathway	16/468	0.1292644778714601	1.0	0	0	1.3675213675213675	2.797804796427173	F12;VEGFB;GATA4;ITPR3;ARRB2;ACTN4;DGKZ;TUBA4A;GNGT2;GNB2;BSG;GNB3;GAS6;ZFPM2;ALDOA;BCAR1
Adrenergic pathway	6/137	0.12936659917835788	1.0	0	0	1.7518248175182483	3.582665782699951	PDE6C;ITPR3;PLCH2;CACNA1F;PLCD3;MAPK12
Glutathione metabolism	3/51	0.13483744322316818	1.0	0	0	2.352941176470588	4.714553765545066	GPX1;GPX4;GSTP1
ALK1 pathway	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	TLX2;ARRB2
Estrogen receptor transcription factor targets	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	NCOR2;CTBP1
Segmentation clock	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	DVL1;KREMEN2
Signaling by insulin receptor	5/109	0.13784796080850112	1.0	0	0	1.834862385321101	3.6359705219282574	FGF17;STK11;EEF2K;EIF4EBP1;MLST8
Nuclear beta-catenin signaling and target gene transcription regulation	4/80	0.14019643720239597	1.0	0	0	2.0	3.9294214339112856	CTBP1;CDKN2A;SP5;CACNA1G
Opioid signaling	4/80	0.14019643720239597	1.0	0	0	2.0	3.9294214339112856	GNGT2;GNB2;GNB3;ITPR3
Mitochondrial beta-oxidation of unsaturated fatty acids	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	ECI1
Multi-drug resistance factors	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	GSTP1
Neurotransmitter clearance in the synaptic cleft	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	COMT
Vitamin B6 metabolism	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	PDXP
MAP kinase signaling pathway	4/81	0.14476468418008995	1.0	0	0	1.9753086419753085	3.817571797652061	TRAF2;MAP3K6;MAPK12;MAP3K5
Cooperation of prefoldin and TriC/CCT  in actin and tubulin folding	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	TUBB4B;TUBA4A
EGFR downregulation	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	SH3GL2;EPN1
Pentose phosphate pathway	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	PFKL;ALDOA
Protein folding	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	TBCD;TUBB4B;TUBA4A
Platelet homeostasis	4/82	0.14939050479141397	1.0	0	0	1.951219512195122	3.709642075934028	GNGT2;GNB2;GNB3;ITPR3
Signal transduction	31/1020	0.1517326694824849	1.0	0	0	1.2156862745098038	2.292340661131648	LAMA5;CHRM4;ITPR3;ARRB2;HTR6;GNGT2;EEF2K;BSG;GRM8;MLST8;EIF4EBP1;E2F1;FFAR4;DRD4;JAG2;ARHGEF16;MIB2;MATK;MYO9B;ARAP1;DGKZ;MAPK12;DNM1;EPN1;NCOR2;FGF17;COL5A1;GNB2;GNB3;ARHGEF1;BCAR1
Oocyte meiosis	5/113	0.15333823216929846	1.0	0	0	1.7699115044247786	3.3187772207916013	CAMK2B;MAD2L2;ITPR3;PKMYT1;MAPK12
Apoptosis	9/242	0.15409546113463288	1.0	0	0	1.487603305785124	2.7820904000066613	ENDOG;UNC5A;CDKN2A;DAPK3;E2F1;BAX;TRAF2;TP73;PLEC
Cell cycle: G1/S checkpoint	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	CDKN2A;E2F1
Dual incision reaction in TC-NER	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	XAB2;POLR2E
Extension of telomeres	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	LIG1;POLD1
Multi-step regulation of transcription by PITX2	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	DVL1;KREMEN2
Recycling pathway of cell adhesion molecule L1	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	SH3GL2;DNM1
TAp63 pathway	3/55	0.15835797713897543	1.0	0	0	2.1818181818181817	4.020866466848246	CDKN2A;BAX;AEN
ECM-receptor interaction	4/84	0.15880894471190304	1.0	0	0	1.9047619047619047	3.5048636282938084	LAMA5;COL5A1;LAMA3;THBS4
Small cell lung cancer	4/84	0.15880894471190304	1.0	0	0	1.9047619047619047	3.5048636282938084	LAMA5;LAMA3;E2F1;TRAF2
Calcium signaling pathway	7/178	0.1592170991083891	1.0	0	0	1.5730337078651684	2.8904283672266273	CAMK2B;HTR6;ITPKA;ITPR3;CACNA1F;PLCD3;CACNA1G
Acetylcholine biosynthesis	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	PEMT
Arachidonate epoxygenase/epoxide hydrolase pathway	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	GSTP1
Attachment of GPI anchor to uPAR	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	GPAA1
Creatine metabolism	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	GAMT
Cyanoamino acid metabolism	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	SHMT2
FGFR3b ligand binding and activation	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	FGF17
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	SLC29A1
Wnt/LRP6 signaling	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	KREMEN2
ADP-ribosylation factor	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	CLTB;ARAP1
Myc active pathway	4/85	0.16359856361460354	1.0	0	0	1.8823529411764706	3.4076981359319904	MTA1;HMGA1;BAX;TK1
Thromboxane A2 receptor signaling	3/56	0.164424419508895	1.0	0	0	2.142857142857143	3.868509150496886	ARHGEF1;ARRB2;DNM1
Cell cycle	15/453	0.16548252535003938	1.0	0	0	1.3245033112582782	2.3826353334417822	CDT1;CDKN2C;NUMA1;LIG1;CDKN2A;CEP131;PPP2R3B;TUBB4B;PKMYT1;TUBA4A;GADD45G;MAD2L2;POLD1;E2F1;MYBL2
Leukocyte transendothelial migration	5/117	0.16951475631185442	1.0	0	0	1.7094017094017093	3.0338723043827405	CYBA;ACTN4;MAPK12;BCAR1;SIPA1
Calcium regulation in the cardiac cell	6/149	0.17044793665898042	1.0	0	0	1.610738255033557	2.8499200843945487	CAMK2B;CHRM4;GNB2;GNB3;ITPR3;ARRB2
Apoptosis intrinsic pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	E2F1;BAX
Gap junction trafficking and regulation	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	CLTB;DNM1
Glutamate binding and activation of AMPA receptors and synaptic plasticity	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	CAMK2B;AKAP5
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	DVL1;KREMEN2
TNFR1 signaling pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	TRAF2;LMNB2
Tumor necrosis factor (TNF) pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	TRAF2;MAP3K5
Huntington's disease	7/184	0.17873041141519813	1.0	0	0	1.5217391304347827	2.6202471368065696	GPX1;NDUFB7;NDUFS7;CLTB;POLR2E;BAX;NDUFV1
DNA strand elongation	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	LIG1;POLD1
Gluconeogenesis	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	ALDOA;ENO3
Stathmin and breast cancer resistance to antimicrotubule agents	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	CAMK2B;TUBA4A
Transport of vitamins, nucleosides, and related molecules	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	SLCO4A1;SLC29A1
Chromatin remodeling by nuclear receptors to facilitate initiation of transcription in carcinoma cells	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	NCOR2
Cross-presentation of particulate exogenous antigens (phagosomes)	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	CYBA
Integration of provirus	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	HMGA1
Mitochondrial beta-oxidation of saturated fatty acids	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	ACADS
Thiamine metabolism	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	PHPT1
Notch signaling pathway	5/121	0.18632308107100282	1.0	0	0	1.6528925619834711	2.7773109373466376	JAG2;NCOR2;CTBP1;DVL1;DNM1
Neurotrophic factor-mediated Trk receptor signaling	3/60	0.18933665205922548	1.0	0	0	2.0	3.3284572412017854	GIPC1;MATK;DNM1
Glycine, serine and threonine metabolism	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	GAMT;SHMT2
Hypothetical network for drug addiction	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	CAMK2B;DRD4
Netrin-mediated signaling events	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	UNC5A;BCAR1
Signaling by Robo receptor	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	ROBO3;PAK4
Syndecan 4 pathway	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	GIPC1;LAMA3
Signaling by PDGF	5/122	0.1906172284083889	1.0	0	0	1.6393442622950818	2.717193281076577	COL5A1;MLST8;ITPR3;THBS4;BCAR1
Glucose metabolism	3/61	0.19571013951815233	1.0	0	0	1.9672131147540983	3.2087618250165857	PFKL;ALDOA;ENO3
Fluoropyrimidine activity	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	TK1;SLC29A1
Global genomic nucleotide excision repair (GG-NER)	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	LIG1;POLD1
Glucagon signaling in metabolic regulation	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	GNB2;GNB3
PIP biosynthesis at the plasma membrane	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	INPP5J;PIP5K1C
Syndecan 2 pathway	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	LAMA3;BAX
G alpha (s) signaling events	5/125	0.2037060161721424	1.0	0	0	1.5999999999999999	2.545723874740078	HTR6;GNGT2;GNB2;GNB3;RAMP1
Activation of pro-caspase 8	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	TRAF2
Axonogenesis regulation by p75 neurotrophin receptor	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ARHGEF1
Elevation of cytosolic calcium levels	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ITPR3
PI3K/AKT signalling	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	MLST8
Polyadenylation of mRNA	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CPSF1
Pyrimidine salvage reactions	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	TK1
Sodium/calcium exchangers	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	SLC24A4
Neurotrophin signaling pathway	5/126	0.20813463115565656	1.0	0	0	1.5873015873015872	2.491381180151027	CAMK2B;BAX;MAPK12;MAP3K5;TP73
Fatty acid beta oxidation	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	ECI1;ACADS
TOR signaling	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	EIF4EBP1;MLST8
Class B GPCRs (secretin family receptors)	4/95	0.21407627612000896	1.0	0	0	1.6842105263157894	2.5960806686302367	GNGT2;GNB2;GNB3;RAMP1
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	4/95	0.21407627612000896	1.0	0	0	1.6842105263157894	2.5960806686302367	EHMT2;NFIC;POLR2E;POLRMT
Collagen biosynthesis and modifying enzymes	3/64	0.21512892953081966	1.0	0	0	1.875	2.8809707969055927	COL5A1;COL7A1;COLGALT1
Validated nuclear estrogen receptor alpha network	3/64	0.21512892953081966	1.0	0	0	1.875	2.8809707969055927	NCOR2;MTA1;ABCA3
Base excision repair	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	LIG1;POLD1
Integrated cancer pathway	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	E2F1;BAX
PIK3C1/AKT pathway	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	MLST8;MAP3K5
PDGFB signaling pathway	5/129	0.2216043819346316	1.0	0	0	1.5503875968992247	2.336219457722892	PIN1;ACTN4;ARAP1;BCAR1;SIPA1
Glioma	3/65	0.2216910070831208	1.0	0	0	1.8461538461538463	2.7811767260910543	CAMK2B;CDKN2A;E2F1
Abacavir transport and metabolism	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	GUK1
Apoptotic DNA fragmentation and tissue homeostasis	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	ENDOG
Calcitonin-like ligand receptors	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	RAMP1
Free radical-induced apoptosis	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	GPX1
Netrin mediated repulsion signals	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	UNC5A
Purine catabolism	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	GPX1
Ran role in mitotic spindle regulation	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	NUMA1
Signal-dependent regulation of myogenesis by corepressor MITR	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	CAMK2B
Interleukin-4 regulation of apoptosis	9/267	0.22640444203014795	1.0	0	0	1.348314606741573	2.0028300843655	TMEM259;NINJ1;LAMA3;CLTB;ABHD8;MED16;GAS6;KCNK3;RAB11B
Thyroid-stimulating hormone signaling pathway	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	E2F1;SCRIB;RAP1GAP
G1 to S cell cycle control	3/67	0.23493078009641188	1.0	0	0	1.7910447761194028	2.594264527179215	CDKN2C;CDKN2A;E2F1
SIDS susceptibility pathways	3/67	0.23493078009641188	1.0	0	0	1.7910447761194028	2.594264527179215	FEV;GNB3;CC2D1A
Carbohydrate metabolism	8/235	0.2361342394330512	1.0	0	0	1.3617021276595744	1.9654193355047176	PFKL;CHPF;B3GAT3;ST3GAL4;ALDOA;SLC37A4;ENO3;GALK1
ALK in cardiac myocytes	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	DVL1;GATA4
FRA pathway	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	CDKN2A;LAMA3
ALK2 pathway	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	TLX2
Acetylcholine neurotransmitter release cycle	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	CPLX1
CDC6 association with the ORC-origin complex	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	E2F1
Cardiac protection against reactive oxygen species	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	GPX1
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	GAS6
Methylation	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	COMT
Norepinephrine neurotransmitter release cycle	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	CPLX1
Purine ribonucleoside monophosphate biosynthesis	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	IMPDH1
Recruitment of NuMA to mitotic centrosomes	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	NUMA1
SUMOylation as a mechanism to modulate CtBP-dependent gene responses	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	CTBP1
Signaling by VEGF	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	VEGFB
Signaling by activated point mutants of FGFR1	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	FGF17
Transport of organic anions	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	SLCO4A1
Valine, leucine and isoleucine biosynthesis	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	VARS2
p38 alpha/beta MAPK downstream pathway	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	EIF4EBP1;HSPB1
GnRH signaling pathway	4/101	0.24619177364498787	1.0	0	0	1.584158415841584	2.220426897571902	CAMK2B;ITPR3;CACNA1F;MAPK12
TNF-alpha signaling pathway	4/101	0.24619177364498787	1.0	0	0	1.584158415841584	2.220426897571902	BAX;CYBA;TRAF2;MAP3K5
Signaling by ERBB2	4/102	0.25164686509502815	1.0	0	0	1.5686274509803921	2.164280005079847	MATK;MLST8;ITPR3;STUB1
NGF signaling via TRKA from the plasma membrane	5/136	0.2539845336325637	1.0	0	0	1.4705882352941175	2.0154145662175362	MLST8;ITPR3;SH3GL2;DNM1;MAPK12
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	CAMK2B;BCAR1
FAS pathway and stress induction of heat shock protein regulation	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	HSPB1;LMNB2
Vitamin A and carotenoid metabolism	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	RBP7;RBP4
CDC42 signaling events	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	TNK2;BCAR1;PAK4
Pancreatic cancer	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	CDKN2A;E2F1;VEGFB
RIG-I-like receptor signaling pathway	3/71	0.26179144524840503	1.0	0	0	1.6901408450704225	2.2651387651401085	PIN1;TRAF2;MAPK12
Rac1 cell motility signaling pathway	3/71	0.26179144524840503	1.0	0	0	1.6901408450704225	2.2651387651401085	CYBA;PIP5K1C;BCAR1
Beta-arrestins in GPCR desensitization	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	DNM1
Caspase-mediated cleavage of cytoskeletal proteins	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	PLEC
Dopamine neurotransmitter release cycle	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	CPLX1
FGFR3 ligand binding and activation	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	FGF17
Gamma-aminobutyric acid receptor life cycle	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	DNM1
SODD/TNFR1 signaling pathway	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	TRAF2
Serotonin receptors	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	HTR6
Tandem pore domain potassium channels	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	KCNK3
PAC1 receptor pathway	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	PLCH2;PLCD3
p53 signaling pathway	5/139	0.26820709009249616	1.0	0	0	1.4388489208633093	1.8935192412132424	PIDD1;GPX1;E2F1;BAX;TP73
FOXM1 transcription factor network	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	CDKN2A;CENPB
Tyrosine metabolism	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	MIF;COMT
Chronic myeloid leukemia	3/73	0.275367586439176	1.0	0	0	1.643835616438356	2.1199699658854088	CTBP1;CDKN2A;E2F1
Advanced glycosylation endproduct receptor signaling	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	PRKCSH
Death receptor signaling	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	TRAF2
FGFR4 ligand binding and activation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	FGF17
Ghrelin-mediated regulation of food intake and energy homeostasis	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	IGFBP2
Glucose-dependent insulinotropic polypeptide (GIP) biosynthesis, secretion, and inactivation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	GATA4
N-glycan trimming in the ER and calnexin/calreticulin cycle	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	PRKCSH
Organic anion transporters	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	SLC17A7
Purine salvage	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	AMPD2
TACI and BCMA stimulation of B cell immune responses	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	TRAF2
p27 phosphorylation regulation during cell cycle progression	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	E2F1
Integrins in angiogenesis	3/74	0.28218271785894006	1.0	0	0	1.6216216216216217	2.051676457611424	COL5A1;COL7A1;BCAR1
Seven transmembrane receptor signaling through beta-arrestin	3/74	0.28218271785894006	1.0	0	0	1.6216216216216217	2.051676457611424	PDE6C;MAPK12;MAP3K5
Fatty acid metabolism	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	ECI1;ACADS
VEGF, hypoxia, and angiogenesis	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	CAMK2B;BCAR1
G alpha i pathway	4/108	0.2848542905983054	1.0	0	0	1.4814814814814814	1.8604110970526841	ITPR3;RAP1GAP;MAPK12;MAP3K5
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/75	0.2890124517878938	1.0	0	0	1.5999999999999999	1.986056809642578	ACTN4;CACNA2D4;CACNA1F
Glycolysis and gluconeogenesis	3/75	0.2890124517878938	1.0	0	0	1.5999999999999999	1.986056809642578	PFKL;ALDOA;ENO3
Voltage-gated potassium channels	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	KCNH3;KCNV2
Activation of Rac	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	PAK4
HIV-1 early elongation complex formation	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	NELFA
Initiation of the second proteolytic cleavage of Notch receptor by receptor-ligand binding	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	JAG2
Intronless pre-mRNA processing	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	CPSF1
Leading strand biosynthesis	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	POLD1
MAP kinase inactivation of SMRT corepressor	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	NCOR2
Sema3A-plexin repulsion signaling by inhibiting integrin adhesion	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	PIP5K1C
Signaling by NOTCH2	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	JAG2
Viral messenger RNA biosynthesis	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	POLR2E
Transcription	6/181	0.2999028666848604	1.0	0	0	1.3259668508287292	1.5968574158723403	CPSF1;EHMT2;NFIC;POLR2E;NELFA;POLRMT
Gastrin pathway	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	CHGA;CDKN2A
Heart development	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	VEGFB;GATA4
Lysine degradation	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	EHMT2;COLGALT1
Epidermal growth factor receptor (EGFR) pathway	4/111	0.3016982914677775	1.0	0	0	1.4414414414414414	1.7273193453695646	RHOT2;EEF2K;CDKN2A;MAPK12
Signaling by EGFR in cancer	4/111	0.3016982914677775	1.0	0	0	1.4414414414414414	1.7273193453695646	MLST8;ITPR3;SH3GL2;EPN1
Mitochondrial pathway of apoptosis: caspases	3/77	0.30270573541973567	1.0	0	0	1.5584415584415583	1.8623284918379568	AIP;HSPB1;TRAF2
Amino sugar and nucleotide sugar metabolism	2/45	0.31071849114810757	1.0	0	0	1.7777777777777777	2.077987466447498	UAP1L1;GALK1
RNA polymerase III transcription	2/45	0.31071849114810757	1.0	0	0	1.7777777777777777	2.077987466447498	NFIC;POLR2E
Protein metabolism	13/442	0.31422825152061723	1.0	0	0	1.176470588235294	1.3619242840921861	TOMM40;GPAA1;PRKCSH;TBCD;TUBB4B;EEF2;TUBA4A;RPS15;DPM3;ST3GAL4;EIF4EBP1;TIMM17B;GAS6
Biogenic amine biosynthesis	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	COMT
Calcium signaling by HBx of hepatitis B virus	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CAMK2B
Coagulation intrinsic pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	F12
Cyclin A/B1-associated events during G2/M transition	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	PKMYT1
Glycosylation of mammalian N-linked oligosaccarides	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	ST3GAL4
Stress induction of HSP regulation	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	HSPB1
Signaling by NGF	7/221	0.3164880923086353	1.0	0	0	1.2669683257918551	1.4576086204528695	ARHGEF16;MLST8;ARHGEF1;ITPR3;SH3GL2;DNM1;MAPK12
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	LAMA5;LAMA3
Transfer RNA aminoacylation	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	VARS2;FARSA
Actions of nitric oxide in the heart	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	CAMK2B;GUCY2D
Delta Np63 pathway	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	COL5A1;CDKN2A
LKB1 signaling events	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	STK11;MLST8
BDNF signaling pathway	8/261	0.3295150613674804	1.0	0	0	1.2260536398467432	1.3610828705832938	NUMA1;LAMA3;HSPB1;BAX;H1FX;PLP2;ROR2;RAMP1
CXCR4 signaling pathway	4/116	0.32999523901017713	1.0	0	0	1.379310344827586	1.5292097267138929	MLST8;ARRB2;DNM1;BCAR1
Vascular smooth muscle contraction	4/116	0.32999523901017713	1.0	0	0	1.379310344827586	1.5292097267138929	ITPR3;ARHGEF1;CACNA1F;RAMP1
EGFR1 pathway	5/152	0.33147910049577933	1.0	0	0	1.3157894736842104	1.4528822586911272	NINJ1;E2F1;HSPB1;MYBL2;PKMYT1
Interleukin-10 anti-inflammatory signaling pathway	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	MAP3K5
N-glycan precursor substrate biosynthesis	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	DPM3
Other semaphorin interactions	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PLXND1
Protein kinase A (PKA) at the centrosome	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PKN1
Rb tumor suppressor/checkpoint signaling in response to DNA damage	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	E2F1
Riboflavin metabolism	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PHPT1
Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	GATA4
ATM-dependent DNA damage response	3/82	0.33702536869684624	1.0	0	0	1.4634146341463412	1.5916054733134235	DVL1;BAX;TP73
ATM pathway	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	CTBP1;TP73
Chondroitin sulfate/dermatan sulfate metabolism	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	CHPF;B3GAT3
TGF-beta regulation of extracellular matrix	16/565	0.34062273071404003	1.0	0	0	1.1327433628318584	1.219941692840484	CAMK2B;CTBP1;CDKN2A;CCNF;ARHGEF16;FBLN1;PDIA5;CHERP;MTA1;IMPA2;COL7A1;NINJ1;EIF4EBP1;E2F1;ZFPM2;MAP3K5
HIV life cycle	4/118	0.34136073989964455	1.0	0	0	1.3559322033898304	1.4573769119991022	LIG1;HMGA1;POLR2E;NELFA
Amino acid and oligopeptide SLC transporters	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	SLC17A7;SLC38A3
Ceramide signaling pathway	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	BAX;TRAF2
G alpha 12 pathway	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	MAPK12;MAP3K5
Glycerolipid metabolism	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	CEL;DGKZ
Activation of BH3-only proteins	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	E2F1
Atypical NF-kappaB pathway	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	ARRB2
Beta-arrestin-dependent recruitment of Src kinases in GPCR signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	DNM1
Cell to cell adhesion signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	BCAR1
Energy-dependent regulation of mTOR by LKB1-AMPK	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	STK11
Estrogen metabolism	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	COMT
GRB2-SOS provides linkage to MAPK signaling for integrins	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	BCAR1
Insulin-like growth factor (IGF) activity regulation by insulin-like growth factor binding proteins (IGFBPs)	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	IGFBP2
Nitric oxide metabolism	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	NOSIP
Phenylalanine metabolism	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	MIF
Synaptic proteins at the synaptic junction	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	GUK1
Unblocking of NMDA receptor, glutamate binding and activation	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CAMK2B
Cell junction organization	3/84	0.35074081138659435	1.0	0	0	1.4285714285714284	1.4967253676962142	LAMA3;CDH24;PLEC
Differentiation pathway in PC12 cells	3/84	0.35074081138659435	1.0	0	0	1.4285714285714284	1.4967253676962142	PLCH2;PLCD3;MAP3K5
G alpha s pathway	4/120	0.3527373794502049	1.0	0	0	1.3333333333333333	1.3893752886576032	PDE6C;CACNA1F;MAPK12;MAP3K5
Phosphatidylinositol metabolism	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	INPP5J;PIP5K1C
Wnt signaling pathway	7/231	0.35690264551808415	1.0	0	0	1.2121212121212122	1.2488390739665034	CAMK2B;CTBP1;DVL1;PRICKLE2;PIN1;KREMEN2;CSNK1G2
Asparagine N-linked glycosylation	3/85	0.3575874776802259	1.0	0	0	1.4117647058823528	1.4518238879557512	DPM3;PRKCSH;ST3GAL4
Integrin cell surface interactions	3/85	0.3575874776802259	1.0	0	0	1.4117647058823528	1.4518238879557512	LAMA5;BSG;BCAR1
Progesterone-mediated oocyte maturation	3/86	0.36442414082249097	1.0	0	0	1.3953488372093021	1.4085165595114748	MAD2L2;PKMYT1;MAPK12
Type I interferon (interferon-alpha/beta) pathway	2/51	0.36564128501908433	1.0	0	0	1.5686274509803921	1.578200034140809	PTP4A3;PTPRN
Activated AMPK stimulation of fatty-acid oxidation in muscle	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	STK11
Botulinum neurotoxicity	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	STX3
CDK regulation of DNA replication	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	CDT1
Fatty acyl-CoA biosynthesis	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	TECR
Phosphatidylcholine biosynthesis	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PEMT
Pre-NOTCH processing in Golgi	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	ST3GAL4
Serotonin receptor 4/6/7 and NR3C signaling	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	HTR6
TNFR2 signaling pathway	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	TRAF2
Rho GTPase cycle	4/123	0.36980155943674486	1.0	0	0	1.3008130081300813	1.294034137319875	RHOT2;ARHGEF16;MYO9B;ARAP1
Drug metabolism: other enzymes	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	IMPDH1;TK1
Mitochondrial protein import	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	TOMM40;TIMM17B
Taste transduction	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	GNB3;ITPR3
p75 neurotrophin receptor-mediated signaling	4/124	0.37548462272034455	1.0	0	0	1.2903225806451613	1.263919690443347	RTN4R;ARHGEF16;E2F1;ARHGEF1
Androgen receptor signaling, proteolysis, and transcription regulation	3/88	0.3780598863986252	1.0	0	0	1.3636363636363635	1.3264127267525516	NCOR2;STUB1;GAS6
HIF-1 degradation in normoxia	3/88	0.3780598863986252	1.0	0	0	1.3636363636363635	1.3264127267525516	CAMK2B;MTA1;MAPK12
Calcineurin in effects in keratinocyte differentiation	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CAMK2B
Cell cycle progression regulation by PLK3	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	BAX
Class C GPCRs (metabotropic glutamate and pheromone receptors)	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	GRM8
G-protein-independent seven transmembrane receptor signaling	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	MAPK12
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CDKN2A
Mitochondrial gene expression	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	POLRMT
PTEN-dependent cell cycle arrest and apoptosis	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	BCAR1
Platelet calcium homeostasis	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	ITPR3
Ras activation upon calcium influx through NMDA receptor	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CAMK2B
Signaling by NODAL	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	DRAP1
Androgen receptor regulation of biosynthesis and transcription	2/53	0.38359202335177106	1.0	0	0	1.5094339622641508	1.4463029892393837	EHMT2;PKN1
Gap junction pathway	3/90	0.39163344766088204	1.0	0	0	1.3333333333333333	1.2499052788690577	ITPR3;TUBB4B;TUBA4A
Non-small cell lung cancer	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	CDKN2A;E2F1
Phospholipase C-mediated cascade	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	FGF17;ITPR3
Spliceosome	4/127	0.3925027195065659	1.0	0	0	1.2598425196850394	1.178219607060823	SART1;XAB2;SF3A2;CHERP
Transmembrane transport of small molecules	12/432	0.39625790271578326	1.0	0	0	1.111111111111111	1.0285444558081018	ABCA2;SLC24A4;GNGT2;SLCO4A1;ABCA3;GNB2;GNB3;ABCA7;SLC17A7;SLC29A1;SLC38A3;SLC37A4
Apoptotic signaling in response to DNA damage	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	BAX
Cell differentiation pathway	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	TLX2
Chondroitin sulfate biosynthesis	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	CHPF
Gene expression regulation in pancreatic beta cells	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	NEUROD1
Golgi-associated vesicle biogenesis	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	SH3GL2
Hypertrophy pathway	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	EIF4EBP1
Interleukin-3 regulation of hematopoietic cells	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	MATK
N-glycan antennae elongation in the medial/trans-Golgi	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	ST3GAL4
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	EIF4EBP1
Urea cycle and metabolism of amino groups	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	GAMT
Calcineurin-dependent NFAT signaling role in lymphocytes	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	FKBP8;AKAP5
Extracellular matrix organization	3/93	0.41184736294433893	1.0	0	0	1.2903225806451613	1.1446483568607568	COL5A1;COL7A1;COLGALT1
Biosynthesis of unsaturated fatty acids	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	TECR
CD28-dependent PI3K/Akt signaling	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	MLST8
Mitochondrial tRNA aminoacylation	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	VARS2
p38 MK2 pathway	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	HSPB1
Alzheimer's disease	5/169	0.4157422524395064	1.0	0	0	1.1834319526627217	1.0386861493789756	NDUFB7;NDUFS7;ITPR3;CACNA1F;NDUFV1
ERBB signaling pathway	3/94	0.418539889978251	1.0	0	0	1.276595744680851	1.1118932898382732	CAMK2B;EIF4EBP1;PAK4
Activation of mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	RPS15;EIF4EBP1
Keratinocyte differentiation	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	TRAF2;MAP3K5
PI3K cascade	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	FGF17;MLST8
Pathogenic Escherichia coli infection	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	TUBB4B;TUBA4A
Pre-NOTCH expression and processing	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	E2F1;ST3GAL4
Transport of inorganic cations/anions and amino acids/oligopeptides	3/95	0.42520717958043197	1.0	0	0	1.263157894736842	1.0802257862809745	SLC24A4;SLC17A7;SLC38A3
Tight junction	4/133	0.42630173637085006	1.0	0	0	1.2030075187969924	1.0256936927515796	ACTN4;LLGL1;TJP3;LLGL2
Double-strand break repair	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	LIG1
Nephrin interactions	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	ACTN4
Nitric oxide signaling pathway	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	CAMK2B
TRAF6 mediated NF-kB activation	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	TRAF2
Arachidonic acid metabolism	2/58	0.4274492922819714	1.0	0	0	1.379310344827586	1.1723029133595582	GPX1;GPX4
Fatty acid, triacylglycerol, and ketone body metabolism	5/173	0.4354316820628668	1.0	0	0	1.1560693641618496	0.9611761472962589	NCOR2;ECI1;TECR;MED16;ACADS
Telomere maintenance	2/59	0.43602582146324703	1.0	0	0	1.3559322033898304	1.1254966967419524	LIG1;POLD1
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	4/135	0.43746801455021006	1.0	0	0	1.1851851851851851	0.9798538494300738	GPX1;IGFBP2;NME2;ABCA7
T cell receptor regulation of apoptosis	16/603	0.4397555192939579	1.0	0	0	1.0613598673300166	0.8719457055650695	NDUFB7;CDKN2A;UHRF1;GSTP1;TONSL;LTBP4;NME3;MIF;EEF2;MAPK12;TBL3;RNF126;HSF1;PALM;E2F1;MYBL2
Blood clotting cascade	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	F12
Downregulation of SMAD2/3-SMAD4 transcriptional activity	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	NCOR2
FGFR ligand binding and activation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	FGF17
Hypoxia and p53 in the cardiovascular system	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	BAX
Post-elongation processing of intronless pre-mRNA	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	CPSF1
Progesterone-initiated oocyte maturation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	PIN1
Proximal tubule bicarbonate reclamation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	SLC38A3
Rho cell motility signaling pathway	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	ARHGEF1
Signaling events mediated by the hedgehog family	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	ARRB2
Visual signal transduction: rods	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	GUCY2D
Oxidative phosphorylation	4/136	0.4430281180785562	1.0	0	0	1.176470588235294	0.9577906341066323	NDUFB7;NDUFA11;NDUFS7;NDUFV1
Natural killer cell receptor signaling pathway	2/60	0.4445323414545099	1.0	0	0	1.3333333333333333	1.0809766233296643	MAPK12;MAP3K5
Wnt signaling pathway and pluripotency	3/98	0.4450435426086273	1.0	0	0	1.2244897959183672	0.9913263098498469	CTBP1;DVL1;PPP2R3B
FGF signaling pathway	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	FGF17;PAK4
HIV genome transcription	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	POLR2E;NELFA
Cytosolic tRNA aminoacylation	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	FARSA
Dorso-ventral axis formation	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	SPIRE2
Lysosome vesicle biogenesis	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	SH3GL2
Signal transduction of S1P receptor	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	MAPK12
Integrin-mediated cell adhesion	3/100	0.4581166423834544	1.0	0	0	1.2	0.9367577395196145	MAPK12;BCAR1;PAK4
T cell receptor signaling pathway	4/139	0.4596056772594075	1.0	0	0	1.1510791366906474	0.8948332437112545	CAMK2B;ARAP1;MAPK12;PAK4
Shigellosis	2/62	0.46132803795917154	1.0	0	0	1.2903225806451613	0.9982527870331739	MAD2L2;MAPK12
RNA polymerase II transcription	3/101	0.4646041358021239	1.0	0	0	1.188118811881188	0.9107757110849387	CPSF1;POLR2E;NELFA
Basigin interactions	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	BSG
Ck1/Cdk5 regulation by type 1 glutamate receptors	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	CAMK2B
Ghrelin pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	BAX
Glutathione conjugation	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	GSTP1
IGF1 receptor signaling through beta-arrestin	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	MAPK12
Maturity onset diabetes of the young	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	NEUROD1
Phosphoinositides and their downstream targets	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PFKL
RNA polymerase I transcription initiation	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	EHMT2
Regulatory RNA pathways	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	POLR2E
CARM1 and regulation of the estrogen receptor	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	NCOR2
Glycosaminoglycan biosynthesis: heparan sulfate	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	B3GAT3
PGC-1a regulation	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CAMK2B
Physiological and pathological hypertrophy  of the heart	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	GATA4
RXR/VDR pathway	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	NCOR2
Steroid biosynthesis	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CEL
Termination of O-glycan biosynthesis	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	ST3GAL4
Tetrasaccharide linker sequence formation in glycosaminoglycan biosynthesis	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	B3GAT3
ERK1/ERK2 MAPK pathway	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	EEF2K;EIF4EBP1
LPA receptor mediated events	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	ARHGEF1;BCAR1
Electron transport chain	3/105	0.4902008924525257	1.0	0	0	1.1428571428571428	0.8147885569156508	NDUFB7;NDUFS7;NDUFV1
HIF-1 transcriptional activity in hypoxia	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	PFKL;ALDOA
Semaphorin interactions	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	PLXND1;PIP5K1C
Signaling by TGF-beta receptor complex	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	NCOR2;STUB1
BAD phosphorylation regulation	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	BAX
CTCF pathway	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	CDKN2A
Cell cycle: G2/M checkpoint	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	CDC34
FSH signaling pathway	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	EIF4EBP1
Glycosphingolipid biosynthesis: lacto and neolacto series	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	ST3GAL4
Oxidative stress	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	CYBA
Proteins and DNA sequences in cardicac structures	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	GATA4
RNA polymerase III transcription initiation from type 2 promoter	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	POLR2E
TNF/stress-related signaling	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	TRAF2
VEGFR1 pathway	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	VEGFB
eIF4E and p70 S6 kinase regulation	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	EIF4EBP1
Adipocytokine signaling pathway	2/67	0.5019777233846834	1.0	0	0	1.1940298507462686	0.8229248191077754	STK11;TRAF2
G alpha 13 pathway	2/67	0.5019777233846834	1.0	0	0	1.1940298507462686	0.8229248191077754	ARHGEF1;MAP3K5
Messenger RNA capping	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	POLR2E
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	GAS6
RNA polymerase III transcription initiation From type 3 promoter	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	POLR2E
TGF-beta receptor activation of SMADs	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	STUB1
TRAIL signaling pathway	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	TRAF2
Epithelial cell signaling in Helicobacter pylori infection	2/68	0.5098678748711668	1.0	0	0	1.176470588235294	0.7924748890682	GIT1;MAPK12
Chemokine signaling pathway	5/189	0.5123161872622005	1.0	0	0	1.0582010582010581	0.7077389325964872	GNGT2;GNB2;GNB3;ARRB2;BCAR1
NFAT involvement in hypertrophy of the heart	2/69	0.5176757123539347	1.0	0	0	1.1594202898550725	0.7633695892092621	CAMK2B;GATA4
Adherens junction actin cytoskeletal organization	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	CDH24
CDO in myogenesis	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MAPK12
Homologous recombination	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	POLD1
IGF1 pathway	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	BCAR1
Influence of Ras and Rho proteins on G1 to S transition	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	E2F1
Matrix metalloproteinases	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	BSG
RNA polymerase	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	POLR2E
T cell receptor calcium pathway	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	AKAP5
Glycosaminoglycan metabolism	3/110	0.5213279209858358	1.0	0	0	1.0909090909090908	0.7105920309159328	CHPF;B3GAT3;ST3GAL4
Hedgehog signaling pathway	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	ARRB2;CSNK1G2
Long-term potentiation	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	CAMK2B;ITPR3
Renal cell carcinoma	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	VEGFB;PAK4
Activation of the pre-replicative complex	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	CDT1
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	DPM3
Butanoate metabolism	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	ACADS
CDC42 activity regulation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	GIT1
Inflammatory response pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	LAMA5
Nectin adhesion pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PIP5K1C
Retinoic acid receptor-mediated signaling	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	NCOR2
Signaling by FGFR1 mutants	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	FGF17
TRAF6-mediated IRF7 activation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	TRAF2
Phase II of biological oxidations: conjugation	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	GSTP1;COMT
S phase	3/112	0.5334862535056254	1.0	0	0	1.0714285714285714	0.6732021162826888	CDT1;LIG1;POLD1
Phagosome	4/154	0.5395222877080957	1.0	0	0	1.0389610389610389	0.6411129177684076	CYBA;TUBB4B;TUBA4A;THBS4
Leishmaniasis	2/72	0.5405975770602098	1.0	0	0	1.111111111111111	0.6834223634393684	CYBA;MAPK12
Insulin signaling pathway	7/277	0.5417763885243376	1.0	0	0	1.0108303249097472	0.6195398570094508	RHOT2;PFKL;MINK1;EIF4EBP1;MAP3K6;MAPK12;MAP3K5
Alpha-V beta-3 integrin/OPN pathway	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	BCAR1
Amino acid transport across the plasma membrane	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SLC38A3
CD28 co-stimulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	MLST8
CD40/CD40L signaling	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	TRAF2
Keratan sulfate/keratin metabolism	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	ST3GAL4
One-carbon metabolism	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SHMT2
Ras family activation regulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	CAMK2B
Post-translational protein modification	5/196	0.5446077411464911	1.0	0	0	1.0204081632653061	0.6200913106861422	DPM3;GPAA1;PRKCSH;ST3GAL4;GAS6
Gastric acid secretion	2/74	0.5554545611303542	1.0	0	0	1.0810810810810811	0.635641590695438	CAMK2B;ITPR3
Alpha-synuclein signaling	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	STUB1
Fibrin clot formation (clotting cascade)	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	F12
Pancreatic beta-cell development regulation	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	NEUROD1
Prothrombin activation intrinsic pathway	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	F12
Sphingolipid de novo biosynthesis	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	CSNK1G2
G alpha (i) signaling events	5/199	0.5581355275127633	1.0	0	0	1.0050251256281406	0.5860838846676963	GNGT2;CHRM4;GNB2;GNB3;DRD4
Negative regulators of RIG-I/MDA5 signaling	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PIN1
Prolactin regulation of apoptosis	3/118	0.5688860293435293	1.0	0	0	1.0169491525423728	0.5736357608562849	PQLC1;F12;MAP3K5
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways	2/76	0.5699678510175187	1.0	0	0	1.0526315789473684	0.5917634962819259	PIN1;TRAF2
VEGF signaling pathway	2/76	0.5699678510175187	1.0	0	0	1.0526315789473684	0.5917634962819259	HSPB1;MAPK12
Transcriptional regulation of white adipocyte differentiation	2/77	0.5770948361053473	1.0	0	0	1.0389610389610389	0.571167444479923	NCOR2;MED16
Induction of apoptosis through DR3 and DR4/5 death receptors	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	TRAF2
N-cadherin signaling events	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	PIP5K1C
Apoptosis regulation	2/78	0.5841351052931448	1.0	0	0	1.0256410256410255	0.5514081827999194	UNC5A;DAPK3
Lysosome	3/121	0.5859537465440404	1.0	0	0	0.9917355371900827	0.5300969487595464	ABCA2;GAA;CLTB
EGF receptor (ErbB1) signaling pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	PIP5K1C
Interleukin-2/PI3K pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	E2F1
MEF2D role in T cell apoptosis	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	CAMK2B
Prion diseases	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	BAX
Signal transduction by L1	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	SH3GL2
Gastrin-CREB signaling pathway via PKC and MAPK	5/206	0.5888998846268371	1.0	0	0	0.9708737864077669	0.5140767814996373	GNGT2;GNB2;GNB3;ITPR3;DGKZ
Glycerophospholipid metabolism	2/79	0.591088531821221	1.0	0	0	1.0126582278481011	0.5324450357053537	PEMT;DGKZ
DNA replication	5/207	0.5931985875695587	1.0	0	0	0.966183574879227	0.5045662316492779	CDT1;RNASEH2A;LIG1;POLD1;E2F1
Cardiac muscle contraction	2/80	0.5979550492708914	1.0	0	0	1.0	0.5142396963001198	CACNA2D4;CACNA1F
Glycogen metabolism	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	PPP2R3B
SNARE interactions in vesicular transport	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	STX3
Signaling to ERKs	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	MAPK12
Transport to the Golgi and subsequent modification	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	ST3GAL4
SLC-mediated transmembrane transport	6/251	0.6011083104129185	1.0	0	0	0.9561752988047808	0.486674240979301	SLC24A4;SLCO4A1;SLC17A7;SLC29A1;SLC38A3;SLC37A4
Interleukin-1 signaling pathway	3/125	0.608029043614279	1.0	0	0	0.96	0.4776313238922669	UBE2S;HSPB1;MAPK12
Activation of NMDA receptor upon glutamate binding and postsynaptic events	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	CAMK2B
Latent infection of Homo sapiens with Mycobacterium tuberculosis	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	CYBA
PI3K/AKT activation	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	MLST8
Platelet aggregation (plug formation)	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	BCAR1
Regular glucocorticoid receptor pathway	2/82	0.611427375574375	1.0	0	0	0.975609756097561	0.4799600929754372	PPP5C;BAX
T cell signal transduction	2/83	0.6180333278447322	1.0	0	0	0.963855421686747	0.4638196572792209	MAPK12;MAP3K5
EGFR interaction with phospholipase C-gamma	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	ITPR3
Signaling events mediated by HDAC class II	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	NCOR2
Striated muscle contraction	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	ACTN4
Transport of mature mRNAs derived from intronless transcripts	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	CPSF1
Triglyceride biosynthesis	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	TECR
Signaling by FGFR in disease	3/128	0.6240634251777476	1.0	0	0	0.9375	0.44203431831088424	FGF17;MLST8;ITPR3
E-cadherin nascent AJ-like junctions pathway	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	PIP5K1C
FRS2-mediated cascade	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	FGF17
GAB1 signalosome	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	MLST8
HIV-1 transcription initiation	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	POLR2E
Signaling events regulated by Ret tyrosine kinase	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	BCAR1
MicroRNAs in cardiomyocyte hypertrophy	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	DVL1;GATA4
Negative regulation of FGFR signaling	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	FGF17
Pyruvate metabolism and citric acid (TCA) cycle	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	BSG
Non-class A, B, C GPCRs	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	GRM8;DRD4
Parkinson's disease	3/131	0.6396436458477918	1.0	0	0	0.916030534351145	0.4093228040279114	NDUFB7;NDUFS7;NDUFV1
Bioactive peptide-induced signaling pathway	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	CAMK2B
Plasma membrane estrogen receptor signaling	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	BCAR1
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	NCOR2
DNA replication pre-Initiation	2/88	0.649768200720319	1.0	0	0	0.9090909090909091	0.3919450854280717	CDT1;E2F1
Membrane trafficking	3/133	0.649776187680017	1.0	0	0	0.9022556390977443	0.38898703942792145	CLTB;SH3GL2;DNM1
Eukaryotic transcription initiation	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	POLR2E
Hexose transport	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	SLC37A4
Messenger RNA splicing: minor pathway	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	POLR2E
Netrin-1 signaling	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	UNC5A
TWEAK signaling pathway	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	TRAF2
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	BCAR1
Prostate cancer	2/89	0.6558581466108996	1.0	0	0	0.898876404494382	0.37915573334263386	GSTP1;E2F1
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	RAP1GAP
Cleavage of growing transcript in the termination region	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	CPSF1
Type 1 diabetes mellitus	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	PTPRN
Ubiquitin-mediated proteolysis	3/136	0.6645919082134366	1.0	0	0	0.8823529411764706	0.36051361637596113	CDC34;UBE2S;STUB1
G-protein-mediated events	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	ITPR3
HNF3A pathway	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	NFIC
Interactions of HIV Vpr protein with host cellular proteins	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	HMGA1
PI3K events in ERBB2 signaling	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	MLST8
Valine, leucine and isoleucine degradation	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	ACADS
Vasopressin-regulated water reabsorption	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	RAB11B
Capped intron-containing pre-mRNA processing	3/138	0.6742132929355205	1.0	0	0	0.8695652173913043	0.3427902258877473	SF3A2;CPSF1;POLR2E
Signaling by FGFR mutants	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	FGF17
Cell surface interactions at the vascular wall	2/94	0.6850442087819228	1.0	0	0	0.8510638297872339	0.3219335356890655	BSG;GAS6
Fc gamma receptor-mediated phagocytosis	2/94	0.6850442087819228	1.0	0	0	0.8510638297872339	0.3219335356890655	PIP5K1C;DNM1
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	MAPK12
Regulation of NFAT transcription factors	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	E2F1
Regulation of transcription by NOTCH1 intracellular domain	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	NCOR2
GPCR ligand binding	9/410	0.7001477801034289	1.0	0	0	0.8780487804878048	0.3129926503493665	HTR6;GNGT2;CHRM4;GNB2;GRM8;FFAR4;GNB3;RAMP1;DRD4
Activation of chaperones by IRE1 alpha	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	PDIA5
Diurnally regulated genes with circadian orthologs	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	GSTP1
Lipid digestion, mobilization, and transport	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	CEL
N-glycan biosynthesis	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	DPM3
FoxO family signaling	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	CSNK1G2
Dilated cardiomyopathy	2/100	0.7173559974425507	1.0	0	0	0.7999999999999999	0.2657464415359102	CACNA2D4;CACNA1F
Type 2 diabetes mellitus	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	CACNA1G
Melanogenesis	2/101	0.7224620897819041	1.0	0	0	0.792079207920792	0.2574972920889452	CAMK2B;DVL1
Pancreatic secretion	2/101	0.7224620897819041	1.0	0	0	0.792079207920792	0.2574972920889452	ITPR3;CEL
Malaria	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	THBS4
Translation	3/151	0.7317997732945651	1.0	0	0	0.7947019867549668	0.2481443731300127	RPS15;EIF4EBP1;EEF2
Apoptotic execution  phase	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	PLEC
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	B3GAT3
Interleukin-2 receptor beta chain in T cell activation	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	E2F1
Pyruvate metabolism	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	BSG
Signaling events mediated by PTP1B	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	BCAR1
Signaling events mediated by stem cell factor receptor (c-Kit)	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	MATK
Vitamin B12 metabolism	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	SHMT2
Chromosome maintenance	2/103	0.7324409619068384	1.0	0	0	0.7766990291262135	0.24184274906292497	LIG1;POLD1
MHC class II antigen presentation	2/103	0.7324409619068384	1.0	0	0	0.7766990291262135	0.24184274906292497	SH3GL2;DNM1
Integrated breast cancer pathway	3/152	0.7358789564635041	1.0	0	0	0.7894736842105262	0.24212339613573824	STK11;E2F1;BAX
Jak-STAT signaling pathway	4/199	0.7363799418817117	1.0	0	0	0.8040201005025125	0.2460374416635054	CNTFR;PTP4A3;PTPRN;IFNLR1
JNK/MAPK pathway	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	MAP3K5
PI3K pathway	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	CDKN2A
Starch and sucrose metabolism	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	GAA
HIV infection	4/200	0.7399264588953308	1.0	0	0	0.7999999999999999	0.24096358207488217	LIG1;HMGA1;POLR2E;NELFA
Arginine and proline metabolism	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	GAMT
Kit receptor signaling pathway	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	MATK
RANKL signaling pathway	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	TRAF2
ERBB1 downstream pathway	2/106	0.7468366874546598	1.0	0	0	0.7547169811320754	0.22030848476214387	PPP5C;MLST8
Basal cell carcinoma	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	DVL1
RNA polymerase I transcription	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	EHMT2
Transport of mature transcript to cytoplasm	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	CPSF1
Phospholipid metabolism	4/205	0.757118371611701	1.0	0	0	0.7804878048780487	0.2171595460690251	INPP5J;PEMT;PIP5K1C;CSNK1G2
Steroid hormone biosynthesis	1/56	0.758230644178816	1.0	0	0	0.7142857142857142	0.19769118550302078	COMT
Acute myeloid leukemia	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	EIF4EBP1
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	NCOR2
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	5/255	0.7673086944487326	1.0	0	0	0.7843137254901961	0.20773810873567755	SPSB1;CDC34;UBE2S;CYBA;STUB1
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	2/112	0.7736407907197486	1.0	0	0	0.7142857142857142	0.1833197198535737	NCOR2;MED16
RNA degradation	1/59	0.7759629585959883	1.0	0	0	0.6779661016949152	0.1719664364110286	ENO3
Antigen-activated B-cell receptor generation of second messengers	4/211	0.7765754630233049	1.0	0	0	0.7582938388625593	0.1917432853608504	CAMK2B;ITPR3;PIP5K1C;MAPK12
Ephrin receptor B forward pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	DNM1
RAGE pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	CYBA
Lipid and lipoprotein metabolism	10/489	0.7833547092633463	1.0	0	0	0.8179959100204499	0.1997297934258251	NCOR2;ECI1;TECR;INPP5J;PEMT;CEL;PIP5K1C;MED16;ACADS;CSNK1G2
Androgen receptor proteolysis and transcription regulation	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	CDKN2A
Clathrin derived vesicle budding	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	SH3GL2
Leptin signaling pathway	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	BAX
Licensing factor removal from origins	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	CDT1
FSH regulation of apoptosis	5/263	0.7899660236288103	1.0	0	0	0.7604562737642585	0.1792892338484717	PTPRN;DNAJC5;TK1;PPFIA4;MAP3K5
Colorectal cancer	1/62	0.7923971144117075	1.0	0	0	0.6451612903225806	0.15012426177080712	BAX
Disease	14/674	0.7968781622735664	1.0	0	0	0.830860534124629	0.18864977757856924	LIG1;IGFBP2;HMGA1;ITPR3;CYBA;PDIA5;EPN1;RPS15;FGF17;MLST8;POLR2E;STX3;NELFA;SH3GL2
Folate metabolism	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	SHMT2
O-linked glycosylation of mucins	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	ST3GAL4
Endothelins	1/64	0.8026791537609369	1.0	0	0	0.625	0.13737512770713134	BCAR1
MAPK cascade role in angiogenesis	1/64	0.8026791537609369	1.0	0	0	0.625	0.13737512770713134	PLXND1
Interleukin-12-mediated signaling events	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	GADD45G
Destabilization of mRNA by AUF1 (hnRNP D0)	1/66	0.8124529129968876	1.0	0	0	0.6060606060606061	0.12587716344981695	HSPB1
Endochondral ossification	1/66	0.8124529129968876	1.0	0	0	0.6060606060606061	0.12587716344981695	NKX3-2
Metapathway biotransformation	3/174	0.8136944576111964	1.0	0	0	0.689655172413793	0.14218644320310297	CHST8;GSTP1;COMT
Telomerase regulation	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	E2F1
Messenger RNA splicing: major pathway	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	CPSF1
Factors involved in megakaryocyte development and platelet production	2/125	0.8233393070687913	1.0	0	0	0.64	0.12440760480345983	GATA4;ZFPM2
Influenza viral RNA transcription and replication	2/125	0.8233393070687913	1.0	0	0	0.64	0.12440760480345983	RPS15;POLR2E
AP-1 transcription factor network	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	CDKN2A
Antiviral mechanism by interferon-stimulated genes	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	PIN1
Complement and coagulation cascades	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	F12
G alpha q pathway	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	ITPR3
Long-term depression	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	ITPR3
Signaling events mediated by HDAC class I	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	NCOR2
Costimulation by the CD28 family	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	MLST8
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	PKMYT1
Sphingolipid metabolism	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	CSNK1G2
TGF-beta signaling pathway	3/185	0.8447316176810958	1.0	0	0	0.6486486486486487	0.10945058223964875	ARRB2;MAPK12;BCAR1
Adherens junction cell adhesion	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	ACTN4
RANKL regulation of apoptosis and immune response	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	AKAP5
Prolactin activation of MAPK signaling	1/75	0.8507890041924216	1.0	0	0	0.5333333333333333	0.08618193057063522	EIF4EBP1
Diabetes pathways	2/137	0.8602852133033936	1.0	0	0	0.583941605839416	0.08787813216937412	IGFBP2;PDIA5
Peroxisome	1/78	0.8617428383211508	1.0	0	0	0.5128205128205128	0.07630686371389282	ECH1
Signaling by SCF-KIT	1/78	0.8617428383211508	1.0	0	0	0.5128205128205128	0.07630686371389282	MLST8
Antigen processing: cross presentation	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	CYBA
Fc epsilon receptor I signaling pathway	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	MAPK12
Unfolded protein response	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	PDIA5
Biological oxidations	2/139	0.865708767874858	1.0	0	0	0.5755395683453237	0.08299667495615301	GSTP1;COMT
Influenza infection	2/142	0.8734829514627659	1.0	0	0	0.5633802816901409	0.07620657301387117	RPS15;POLR2E
Toll-like receptor signaling pathway regulation	2/142	0.8734829514627659	1.0	0	0	0.5633802816901409	0.07620657301387117	MLST8;MAPK12
SMAD2/3 nuclear pathway	1/82	0.8751096392159449	1.0	0	0	0.4878048780487805	0.0650761456161355	CTBP1
Drug metabolism: cytochrome P450	1/83	0.8782447070953916	1.0	0	0	0.4819277108433735	0.06256868168843485	GSTP1
C-Myb transcription factor network	1/85	0.8842811683327172	1.0	0	0	0.47058823529411764	0.057873036795879476	CDKN2A
NOD signaling pathway	1/85	0.8842811683327172	1.0	0	0	0.47058823529411764	0.057873036795879476	MAPK12
TGF-beta regulation of skeletal system development	1/85	0.8842811683327172	1.0	0	0	0.47058823529411764	0.057873036795879476	THBS4
Messenger RNA processing	3/203	0.8858774092199286	1.0	0	0	0.5911330049261083	0.07163154813509763	SF3A2;CPSF1;POLR2E
Glycerophospholipid biosynthesis	1/86	0.8871864408298141	1.0	0	0	0.46511627906976744	0.055674477287034875	PEMT
mRNA stability regulation by proteins that bind AU-rich elements	1/86	0.8871864408298141	1.0	0	0	0.46511627906976744	0.055674477287034875	HSPB1
Signaling by the B cell receptor (BCR)	2/151	0.8943856512566336	1.0	0	0	0.5298013245033112	0.059135480572440106	MLST8;ITPR3
Adaptive immune system	11/606	0.895235445575959	1.0	0	0	0.7260726072607261	0.08035338639139906	SPSB1;CDC34;UBE2S;MLST8;ITPR3;STUB1;CYBA;RAP1GAP;SIPA1;SH3GL2;DNM1
Salivary secretion	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	ITPR3
Neural crest differentiation	1/91	0.9006565431609593	1.0	0	0	0.43956043956043955	0.045991775475609106	DVL1
Innate immune system	5/319	0.9036391750509783	1.0	0	0	0.6269592476489028	0.06352673411367463	PRKCSH;PIN1;TRAF2;DNM1;MAPK12
Signaling by ERBB4	1/93	0.9055837893531324	1.0	0	0	0.43010752688172044	0.04265611705062928	MLST8
Toll receptor cascades	2/159	0.9102257678711851	1.0	0	0	0.5031446540880503	0.04732710122282368	UBE2S;DNM1
Neuroactive ligand-receptor interaction	4/272	0.9114652814862103	1.0	0	0	0.588235294117647	0.05453045589236704	HTR6;CHRM4;GRM8;DRD4
Interferon-gamma signaling pathway	1/97	0.9147185646131074	1.0	0	0	0.41237113402061853	0.03675828481515323	CAMK2B
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	1/97	0.9147185646131074	1.0	0	0	0.41237113402061853	0.03675828481515323	E2F1
Downstream signaling events Of B cell receptor (BCR)	1/98	0.9168609421701835	1.0	0	0	0.4081632653061224	0.03542835205394167	MLST8
Interferon signaling	2/168	0.9253771860294144	1.0	0	0	0.47619047619047616	0.036930407573484994	CAMK2B;PIN1
Chagas disease	1/104	0.9286330649622538	1.0	0	0	0.38461538461538464	0.028477537194216435	MAPK12
Interleukin-4 signaling pathway	1/104	0.9286330649622538	1.0	0	0	0.38461538461538464	0.028477537194216435	HMGA1
Cytoplasmic ribosomal proteins	1/108	0.9355414383081698	1.0	0	0	0.37037037037037035	0.02467771810747774	RPS15
Interleukin-2 signaling pathway	15/847	0.939595104333009	1.0	0	0	0.7083825265643447	0.044136649292448905	GPX4;NUMA1;ECI1;TECR;TBCD;ARRB2;GADD45G;NFIC;NINJ1;HSF4;PLXNB2;PEMT;SLC17A7;H1FX;CSNK1G2
Class A GPCRs (rhodopsin-like)	3/253	0.9539457666461015	1.0	0	0	0.47430830039525684	0.02236290475689931	HTR6;CHRM4;DRD4
HIV factor interactions with host	1/128	0.9612683274118383	1.0	0	0	0.3125	0.012344278786206636	HMGA1
Cytokine-cytokine receptor interaction	3/265	0.9633104172457615	1.0	0	0	0.45283018867924524	0.016926600069244416	CNTFR;VEGFB;IFNLR1
Systemic lupus erythematosus	1/139	0.9707379214453239	1.0	0	0	0.28776978417266186	0.008546403725324813	ACTN4
Interleukin-5 regulation of apoptosis	1/144	0.9742404896710359	1.0	0	0	0.27777777777777773	0.007249193473197562	SCRIB
Immune system	16/998	0.9808281845727028	1.0	0	0	0.6412825651302604	0.012413933725510513	CAMK2B;PRKCSH;TRAF2;ITPR3;CYBA;RAP1GAP;MAPK12;DNM1;SPSB1;CDC34;UBE2S;MLST8;PIN1;STUB1;SIPA1;SH3GL2
Gene expression	15/968	0.9849251385238634	1.0	0	0	0.6198347107438016	0.009415067477432364	SF3A2;CPSF1;EHMT2;HSPB1;MED16;POLRMT;EEF2;NCOR2;RPS15;NFIC;EIF4EBP1;POLR2E;NELFA;FARSA;VARS2
Amino acid metabolism	1/195	0.9929943651575818	1.0	0	0	0.20512820512820512	0.0014421106702428043	GAMT
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	2/280	0.9934272673470272	1.0	0	0	0.2857142857142857	0.001884122336690201	CAMK2B;PIN1
Signaling by GPCR	13/977	0.9966793281081457	1.0	0	0	0.5322415557830092	0.0017703405635213143	CHRM4;ARHGEF16;ITPR3;DGKZ;HTR6;GNGT2;GNB2;GRM8;FFAR4;GNB3;ARHGEF1;RAMP1;DRD4
Oncostatin M	2/311	0.9967424010361781	1.0	0	0	0.2572347266881029	8.393354316948259E-4	IGFBP2;RAD23A
Olfactory transduction	3/432	0.9987961520261188	1.0	0	0	0.27777777777777773	3.3460366137159556E-4	CAMK2B;GUCY2D;ARRB2
Generic transcription pathway	2/377	0.9992880735184885	1.0	0	0	0.21220159151193632	1.511257340075898E-4	NCOR2;MED16
